- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04211584
The TENDERA Multicenter Clinical Trial (TDR)
November 7, 2022 updated by: Center of Endosurgery and Lithotripsy, Moscow, Russia
Randomized Controlled Trial Comparison Between Traditional ENtry Point and Distal puncturE of RAdial Artery (TENDERA Trial)
TENDERA is a multicenter randomized controlled trial to compare traditional entry point in the radial artery for TRI and distal puncture at the anatomical snuffbox area for transradial Interventions.
The Investigators hypothesized that novel entry point in radial artery may lessen vascular access site complication rate and especially the radial artery late occlusion rate.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
the forearm access will be made using traditional technique what was well described previously in the literature.
The novel puncture site is located in the snuffbox area distal to the traditional radial access point.
Thanks to surrounded anatomical conditions in anatomical snuffbox area vascular access site complications may be lessened comparing to forearm radial access site.
Study Type
Interventional
Enrollment (Actual)
850
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moscow, Russian Federation, 111123
- Center of Endosurgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
age 18-75 primary radial artery puncture radial artery diameter >1,5mm by ultrasound stable coronary disease less than 6F sheath needed patient height >185cm
Exclusion Criteria:
ACS AMI critically ill patients previous TRI procedure Raynaud's disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: forearm radial artery access
traditional access (puncture and cannulation) in the forearm part of the radial artery will be made for further coronary interventions
|
percutaneous coronary interventions in stable patients - diagnostic and treatment
|
|
Active Comparator: anatomic snuffbox access
access in the snuffbox area of the wrist (puncture and cannulation) in the forearm part of the radial artery will be made for further coronary interventions
|
percutaneous coronary interventions in stable patients - diagnostic and treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radial artery late occlusion
Time Frame: 1 year
|
loss of pulse or absent of artery lumen by ultrasound examonation
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
vascular access site related complications
Time Frame: 1 week, 3 months, 6 moths, 1 year
|
hematomas >5cm, bleeding, false aneurism, arterio-venous fistula
|
1 week, 3 months, 6 moths, 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Avtandil M Babunashvili, MD, Center of Endosurgery
- Principal Investigator: Alexander Kaledin, MD, North West state University Saint Petersburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 18, 2017
Primary Completion (Actual)
September 18, 2021
Study Completion (Actual)
October 28, 2022
Study Registration Dates
First Submitted
February 25, 2018
First Submitted That Met QC Criteria
December 23, 2019
First Posted (Actual)
December 26, 2019
Study Record Updates
Last Update Posted (Actual)
November 8, 2022
Last Update Submitted That Met QC Criteria
November 7, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TEN-001/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
all IPD that underlie results
IPD Sharing Time Frame
IV Q of 2021 after the end of the study
IPD Sharing Access Criteria
IPD may be requested by interventional cardiologists or radiologists IPD information may be shared after a request from individual or academic organizations if some concern and questions will raised
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.